edoc

Items where Author is "Haraka, F."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2022 | 2021 | 2020 | 2017 | 2012
Number of items: 5.

2022

Zoller, T. and Mfinanga, E. H. and Zumba, T. B. and Asilia, P. J. and Mutabazi, E. M. and Wimmersberger, D. and Mhimbira, F. and Haraka, F. and Reither, K.. (2022) Symptoms and functional limitations related to respiratory health and carbon monoxide poisoning in Tanzania: a cross sectional study. Environ Health, 21. p. 38.

2021

Haraka, F. and Kakolwa, M. and Schumacher, S. G. and Nathavitharana, R. R. and Denkinger, C. M. and Gagneux, S. and Reither, K. and Ross, A.. (2021) Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis (Review). Cochrane Database Syst Rev, 2021 (4). CD012972.

2020

Haraka, F. and Schumacher, S. G. and Ross, A. and Mantsoki, A. and Gagneux, S. and Reither, K. and Denkinger, C. M.. (2020) Effect of history of tuberculosis on specificity of Xpert MTB/RIF. Eur Respir J, 56 (3). p. 2000343.

2017

Aarnoutse, R. E. and Kibiki, G. S. and Reither, K. and Semvua, H. H. and Haraka, F. and Mtabho, C. M. and Mpagama, S. G. and van den Boogaard, J. and Sumari-de Boer, I. M. and Magis-Escurra, C. and Wattenberg, M. and Logger, J. G. M. and Te Brake, L. H. M. and Hoelscher, M. and Gillespie, S. H. and Colbers, A. and Phillips, P. P. J. and Plemper van Balen, G. and Boeree, M. J.. (2017) Pharmacokinetics, tolerability and bacteriological response of 600, 900 and 1200 mg rifampicin daily in patients with pulmonary TB. Antimicrobial agents and chemotherapy, 61 (11). e01054-17.

2012

Haraka, F. and Rutaihwa, L. K. and Battegay, M. and Reither, K.. (2012) Mycobacterium intracellulare infection in non-HIV infected patient in a region with a high burden of tuberculosis. BMJ case reports, 8 May 2012. p. 3.

This list was generated on Sun Dec 8 16:15:41 2024 CET.